Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-03

Clinical Trial Update: Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial by Diabetech evaluating real-time glucose alert technology for team-based management of Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Diabetech | Conditions: Diabetes Mellitus, Type 1 | Phase 2, Phase 3 | Status: COMPLETED